The Botswana Medicines Regulatory Authority (BoMRA) says all Grand-Pa pain relief products remain suspended
Written by admin on
The Botswana Medicines Regulatory Authority (BoMRA) says all Grand-Pa pain relief products remain suspended from registration and are therefore not allowed in Botswana.
This after a recent public outcry following the circulation of images and persons purporting counterfeit gran Pa’s were being manufactured locally.
A recent statement from the regulator says the suspension follows a decision by the Market Authorization Holder GlaxoSmithKline in South Africa to temporarily halt the supply of these products to Botswana and other markets.
With the product prohibited, BOMRA states that any person found guilty of breaching this law may be liable to a fine of up to P100,000.00 and/or imprisonment for a period not exceeding 10 years.BoMRA further advised the public not to buy or consume unregistered medical products including Grand-Pa products and further urged the local community to regard any Grand-Pa products circulating in the country to be unregistered, counterfeit, substandard, or falsified.